Exploring Clinical Study Experiences of People With Post Traumatic Stress Disorder

Not yet recruiting

• Conditions: Post Traumatic Stress Disorder

• Registration Number: NCT06146049
• Lead Sponsor: Power Life Sciences Inc.

Brief Summary

Participation in post traumatic stress disorder observational study serves as a crucial contribution to advancing medical knowledge and refining the care provided to individuals facing similar health challenges.

The primary objective centers on a meticulous examination of trial completion rates and voluntary withdrawals within this distinct patient population.

Detailed Description

Not available

Study Timeline

• Status Verified: 2023-11
• Study First Submitted: 2023-11-17
• Study First Submitted QC: 2023-11-17
• Last Update Submitted: 2023-11-17
• Study First Posted: 2023-11-24
• Last Update Posted: 2023-11-24
• Study Start: 2024-12
• Primary Completion: 2025-12
• Study Completion: 2026-12

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• Diagnosis of post traumatic stress disorder
• No prior treatment for post traumatic stress disorder
• Willing and able to provide informed consent.

Exclusion Criteria

• Enrolled in another research study
• Psychiatric or behavioral illness
• Inability to provide written informed consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of post traumatic stress disorder study participants who remain in clinical study until completion.	12 months
Rate of patients who decide to enroll in a post traumatic stress disorder clinical research.	3 months

Trial Locations

Locations (1)

Power Life Sciences; 🇺🇸 San Francisco, California, United States